Article
Synthetic surfactants with SP ‐B and SP ‐C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases
24 Oct 2018
Abstract excerpt
Treatment of neonatal respiratory distress syndrome (RDS) using animal-derived lung surfactant preparations has reduced the mortality of handling premature infants with RDS to a 50th of that in the 1960s. The supply of animal-derived lung surfactants is limited and only a part of the preterm babies is treated. Thus, there is a need to develop well-defined synthetic replicas based on key components of natural...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
